ePrints

Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study

Lookup NU author(s): Professor Nicola PaveseORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Nikolcheva T, Pagano G, Anzures-Cabrera J, Trundell D, Kustermann T, Simuni T, Marek K, Pavese N, Seppi K, Stocchi F, Postuma RB, Pross N, Monnet A, Respondek G, Schlegel V, Boak L, Rutten-Jacobs L, Kerchner GA, Brundin P, Svoboda H, Bonni A

Publication type: Article

Publication status: Published

Journal: The Lancet

Year: 2026

Volume: 407

Issue: 10544

Pages: 2227-2240

Print publication date: 30/05/2026

Online publication date: 28/05/2026

Acceptance date: 02/04/2018

ISSN (print): 0140-6736

ISSN (electronic): 1474-547X

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/S0140-6736(26)00865-2

DOI: 10.1016/S0140-6736(26)00865-2

PubMed id: 42208564

Altmetrics

Share